<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:department>Contracts Office</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/04D76F30-BDEF-45A1-82ED-3946C84E9824"><gtr:id>04D76F30-BDEF-45A1-82ED-3946C84E9824</gtr:id><gtr:firstName>Rob</gtr:firstName><gtr:surname>Field</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FJ%2F000CA469"><gtr:id>04C5893D-F879-4F6A-AEE3-9C840C7F0190</gtr:id><gtr:title>Synthesis and Evaluation of Prodrug Iminosugars</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/J/000CA469</gtr:grantReference><gtr:abstractText>In order to dissect the molecular basis of cereal starch metabolism, this project will
take a novel chemical genetics approach through the employment of small
molecule inhibitors to directly manipulate carbohydrate-active enzyme activities in
germinating barley seed.

Based on recent results from Prof Field?s group, this project concerns the
development of a series of enzymatically hydrolysable alpha-1,4-glycosylated
iminosugars with tissue-specific activity in germinating barley seeds, acting as
novel pro-drug inhibitors of alpha-glucosidase and control enzymatically noncleavable
analogues. This will involve the exploration of new chemical and
enzymatic routes for the synthesis of the target molecules, in vitro enzyme
inhibition studies through activity assays against barley glycosidases, analysis of
enzyme-inhibitor complexes by X-ray crystallography, and in vivo analysis on
germinating barley seed (phenotype screening as well as metabolite and
glycoprotein N-glycan analysis).</gtr:abstractText><gtr:fund><gtr:end>2013-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-01-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>49070</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have demonstrated that simple chemical replacements - sulfor for oxygen, for instance - in enzyme inhibitors have a profound impact on biological activity.</gtr:description><gtr:exploitationPathways>Improved drug/agrochemical design</gtr:exploitationPathways><gtr:id>CF078411-80CE-4A38-9C29-7D4EA1C37E74</gtr:id><gtr:outcomeId>54608905e7ddd3.13279696</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A175FF8F-E21E-44D1-811F-D9124C75C991</gtr:id><gtr:title>Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/552a8fabc0fd393c51000006e8d9dd1d"><gtr:id>552a8fabc0fd393c51000006e8d9dd1d</gtr:id><gtr:otherNames>Stegmayr J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58bc0f43b354e5.05736993</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/J/000CA469</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>